Clinical Trial Update: Treatment of Latent Tuberculosis Infection With Isoniazid [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating isoniazid for latent tuberculosis infection; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Latent Tuberculosis Infection
• Tuberculosis

Drugs mentioned

• ISONIAZID (ISONIAZID)

Snippet

Sponsor: Instituto Nacional de Salud Publica, Mexico | Conditions: Tuberculosis | Phase 4 | Status: COMPLETED